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http://dx.doi.org/10.1016/j.pedneo.2Background: Perinatal hypoxia can lead to a wide range of neurological deficits depending on
the differential vulnerability of the involved brain regions to oxygen deprivation. It remains un-
clear whether the differential vulnerability to oxygen deprivation leads to altered neurogen-
esis in the neonatal brain after perinatal hypoxia. The primary objective was to investigate
whether perinatal hypoxia induces deleterious changes in neurogenesis within three represen-
tative brain regions (dentate gyrus of the hippocampus, midbrain, and temporal cortex), with
regards to common pathological areas clinically. The secondary objective was to investigate
whether granulocyte-colony stimulating factor (G-CSF) therapy exerts beneficial effects in
neurogenesis in neonatal rat brains subjected to experimental perinatal hypoxia.
Materials and methods: Rat pups were subjected to experimental perinatal hypoxia on the
tenth day of life (P10). They were then given G-CSF (30 mg/kg, single injection/day, intraper-
itoneal injection, P11e16). The neurogenesis efficacy was analyzed on P17 and the radial-arm
maze task, a memory task for higher cognitive functions such as problem-solving abilities, was
evaluated on P37e58.t of Pediatrics, Kaohsiung Medical University Hospital, Graduate Institute of Medicine, Kaohsiung
t Road, Sanmin District, Kaohsiung City 807, Taiwan.
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G-CSF and neurogenesis in the neonatal brain 381Results: Perinatal hypoxia caused a significant decrease in neurogenesis within the three
representative brain regions, and this deleterious outcome was alleviated by G-CSF
(p < 0.05). In addition, the G-CSF therapy markedly improved the decreased performance
of long-term cognitive functions induced by perinatal hypoxia (p < 0.05).
Conclusion: This study suggests that G-CSF may be a potentially beneficial therapy, at least in
part, through universal recovery of neurogenesis effects in the neonatal brain after perinatal
hypoxia insult.
Copyright ª 2013, Taiwan Pediatric Association. Published by Elsevier Taiwan LLC. All rights
reserved.1. Introduction
In immature brains, cerebral hypoxia contributes to
devastating and lifelong neurological impairment different
from the behavioral impairment in mental retardation and
cerebral palsy.1 Previous studies have reported that hypoxic
injury in young rats can cause extensive neuronal dam-
age.2e5 Perinatal hypoxia causes brain damage in multiple
brain regions including the dentate gyrus, midbrain, and
temporal lobe.6e10 The dentate gyrus of the hippocampus
(an important area for mammalian memory, stress, and
depression) is often discussed due to its sensitivity to oxy-
gen. The midbrain (a functional area for motivation and
habituation) is associated with seizure after hypoxia
insult.11 The temporal lobe with interrelated structure
referred to as the hippocampus is an area involved in
auditory perception and implicated in learning and mem-
ory.12 Although exposure to perinatal hypoxia in these brain
regions has been extensively studied, the mechanisms and
effects of clinical treatment are still unclear.
Granulocyte-colony stimulating factor (G-CSF) is a
glycoprotein of 19.6-kDa that has been used to treat pa-
tients with neutropenia.13 It has been shown to stimulate
the bone marrow to produce stem cells and induce their
mobilization from the bone marrow to the brain, then
inducing neurogenesis in adult animals with stroke to
improve functional outcomes.14e21 Schneider et al18 pro-
posed that G-CSF leads to recovery of hippocampal neuro-
genesis post ischemia. Many studies have focused on G-CSF
therapy in the brains of adults who have had strokes;
however, few studies have focused on the beneficial effects
in neonatal brains post perinatal hypoxia. Our previous
animal model study reported that G-CSF had clinical po-
tential to treat perinatal hypoxia by recovery of neuro-
genesis within the hippocampal CA1 region.22 Hence, in this
study, we investigated the efficacy of G-CSF in the dentate
gyrus of the hippocampus, midbrain, and temporal cortex
of neonatal brains, common pathological areas after peri-
natal hypoxia, using an animal model. We also used an
eight-arm radial maze task to examine the performance in
long-term cognitive functions after perinatal hypoxia with
regards to the cued reference and spatial working memory.
2. Materials and Methods
2.1. Experimental animal protocols
The Animal Care and Use Committee at Kaohsiung Medical
University (Kaohsiung, Taiwan) and National ScienceCouncil (Taipei, Taiwan) approved all experimental pro-
cedures. Sprague-Dawley rats were provided with a 12-hour
light/dark cycle and housed in the animal care facility. The
animals were divided into four experimental groups as
follows: vehicle-control, perinatal hypoxia plus vehicle,
G-CSF alone, and perinatal hypoxia plus G-CSF on postnatal
jDay 10 (P10). The procedures for perinatal hypoxia have
been described previously.11,23,24 The brains of 10e12-day-
old rats are generally accepted to be comparable to
term human infants.25 We removed rats (P10) from the
litter and placed them in an airtight chamber
(30 cm  30 cm  30 cm) on a heating pad at a temperature
of 34C. The concentration of oxygen was then reduced to
5e7% and maintained at this level. In addition, nitrogen gas
was regulated by infusion into the chamber. The rats were
used for this study only when at least one toniceclonic
seizure was observed with low blood oxygen saturation
(<60%) during hypoxia. Recombinant human G-CSF (Kyowa
Hakko Kirin Co. Ltd., Tokyo, Japan; 30 mg/kg, single in-
jection/day, intraperitoneal injection, P11e16) or vehicle-
saline (P11e16) was injected subcutaneously into the rat
pups 1 day after perinatal hypoxia had occurred. The
dosage of G-CSF used (30 mg/kg) was the most effective
dose to alleviate hypoxia-induced damage during the peri-
natal period according to our previous study.22 Brain tissue
specimens of the target brain regions were collected on
P17, and the memory functions and spatial learning were
analyzed at P37eP58.
2.2. Brain tissue slice preparation
On P17, slices (400 mm) of the dentate gyrus, midbrain, and
temporal lobe were collected and immediately placed into
artificial cerebrospinal fluid in a humidified atmosphere of
95% oxygen/5% carbon dioxide at 34.0  0.5C in an incu-
bation chamber for an equilibrium period of at least 1
hour.23 To obtain the target brain regions, the brain slices
were incubated with ice-cold oxygenated artificial cere-
brospinal fluid and then cut into a tissue blocks
(0.1 cm  0.5 cm) within 15 seconds of slicing the tissue.
The brain tissues were then immediately frozen at 80C
until analysis, and all tissue slices were only ever thawed
once.
2.3. Evaluation of neurogenesis
Bromodeoxyuridine (BrdU), a cell type-specific marker, was
used to identify neurogenesis, and double immunofluores-
cence analysis of laser-scanning confocal microscopy was
performed as previously described.18,20,26 The brains were
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phosphate-buffered saline containing 0.2% TritonX-100, pH
7.3 at room temperature with gentle rocking, followed by
incubation for 1 hour at room temperature in blocking so-
lution with gentle rocking on P17. BrdU injections (P14e16,
50 mg/kg q. 12 hours, subcutaneously) were used to detect
the cell proliferation induced by G-CSF. Neuronal nuclei
(NeuN)-staining was performed to detect neuron cells and
the region between 2.8 mm and 4.0 mm behind the bregma
was of interest for neuron counting.27 In each group, brain
regions were taken from a total of 10 sections for each of
the 10 animals. The expressions of NeuN-positive and BrdU-
positive double immunofluorescence were tested following
the instructions of the Roche BrdU labeling and detection
kit. Each coronal section was first treated with primary
BrdU antibody conjugated with FITC (1:250), followed by
treatment with neuron-specific antibodies (NeuN, 1:500;
Chemicon, Temecula, CA, USA). The tissue sections were
analyzed with an Olympus laser-scanning confocal micro-
scope, with green (FITC) and red (Cy3) fluorochromes on
the slides excited by a laser beam at 488 nm and 543 nm,
respectively.Figure 1 Effects of granulocyte-colony stimulating factor (G-CS
dentate gyrus caused by perinatal hypoxia. Colocalization of neur
deoxyuridine (BrdU, green for cell nucleus detection)-positiv
immunofluorescence staining under laser-scanning confocal micros
the combined pictures of the NeuN- and BrdU-positive cells are as f
C1e3 perinatal hypoxia plus vehicle; and (D1e3) perinatal hypoxi
newly generated neurons. Bar Z 50 mm.2.4. Eight-arm radial maze task
As in our previous study,28 an eight-arm radial maze was
used to train rats on two memory tasks. We placed bait in
half of the symmetrical arms, and a black textured insert
was put in each of the remaining four arms. All of the rats
performed one training session/day for 15 days. They were
placed in the center of the maze, facing a different arm in a
quasirandom order in each session. The rat was removed
from the maze when it had eaten the bait from all four
arms or after 15 minutes, whichever came first. After the
bait in an arm had been eaten, it was not replenished. The
arms containing the textured insert served as reference
points in the memory task, and the arms without the insert
served as spatial cues in the memory task because the rats
could not distinguish the arms that they had visited. In this
test, two memory deficits could be recorded: (1) working
memory error (WME), a rat went to an arm with bait that it
had already visited; and (2) reference memory error (RME),
a rat visited an arm with no bait. If the forepaws of the rat
crossed the midline of the arm, it was defined as having
visited that arm. The rats were defined as havingF) therapy in the declining expression of neurogenesis in the
onal nuclei (NeuN, red for neuron identification)- and bromo-
e cells, as assessed on P17, was identified by double-
copy. The NeuN-positive cells (1), BrdU-positive cells (2), and
ollows: (A1e3) vehicle-control; (B1e3) G-CSF alone (30 mg/kg);
a plus G-CSF (30 mg/kg). The arrows reveal the representative
Figure 1 (continued)
G-CSF and neurogenesis in the neonatal brain 383successfully completed the cued reference memory and
spatial working memory tasks when there were no RMEs or
WMEs for at least 2 days within a 3-day period.
2.5. Statistical analysis
All data are presented as mean  standard error of the
mean. Statistical differences were determined by use of
one way analysis of variance (ANOVA) followed by a Bon-
ferroni’s t test for posthoc multiple comparisons. A statis-
tical significance level of p < 0.05 was applied to all tests.
3. Results
3.1. Evaluation of neurogenesis
We first evaluated whether the G-CSF therapy increased
the expression of neurogenesis within the dentate gyrus of
the neonatal brains after perinatal hypoxia. A declining
trend in the coexpression of NeuN-positive with BrdU-
positive cells was revealed in the perinatal hypoxia plus
vehicle group (Figure 1C) compared with the vehicle-
control rats (Figure 1A). By contrast, an increase in the
number of BrdU-positive cells colocalizing with NeuN-
positive cells was observed in the perinatal hypoxia plus
G-CSF group (Figure 1D).
In the midbrain, a decrease in the coexpression of BrdU-
positive with NeuN-positive cells was observed in theperinatal hypoxia group plus vehicle (Figure 2C) compared
with the vehicle-control rats (Figure 2A). However, the
perinatal hypoxia plus G-CSF therapy group showed an in-
crease in the number of BrdU-positive cells colocalizing
with NeuN-positive cells (Figure 2D).
Furthermore, as shown in Figure 3, the perinatal hypoxia
plus vehicle group (Figure 3C) had a significantly decreased
coexpression of BrdU-positive with NeuN-positive cells
compared with the vehicle-control (Figure 3A) and peri-
natal hypoxia plus G-CSF therapy groups (Figure 3D) in the
temporal cortex. The three brain areas in the G-CSF alone
group (Figures 1B, and 3B, 2B) were not significantly
different, as compared with the vehicle control group.
According to our previous study, there was no significant
difference of long-term learning and memory between
G-CSF alone and vehicle control groups.22 Therefore, in the
subsequent experiments we did not perform radial maze for
G-CSF alone group.
In quantitative analysis (Figure 4), the average number
of cells exhibiting double-staining with NeuN-positive and
BrdU-positive within the counted areas showed that G-CSF
therapy had significantly improved the perinatal hypoxia-
induced decrease in neurogenesis, confirming the double
staining of immunofluorescence findings.
3.2. Eight-arm radial maze task
After repeated daily training with the eight-arm maze task,
the long-term cognitive deficits in the working and cued
Figure 2 Granulocyte-colony stimulating factor (G-CSF) therapy restored neurogenesis in the midbrain post perinatal hypoxia. The
neuronal nuclei-positive cells (1), the bromodeoxyuridine-positive cells (2), and the combined pictures of the neuronal nuclei- and
bromodeoxyuridine-positive cells (3) are as follows: (A1e3) vehicle-control; (B1e3)G-CSF alone (30 mg/kg); (C1e3) perinatal hypoxia plus
vehicle; and (D1e3) perinatal hypoxia plusG-CSF (30mg/kg). Thearrows reveal the representativenewly generatedneurons. BarZ50mm.
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Figure 3 Granulocyte-colony stimulating factor (G-CSF) therapy restored neurogenesis in the temporal cortex post perinatal hyp-
oxia. Theneuronal nuclei-positivecells (1), thebromodeoxyuridine-positive cells (2), and thecombinedpicturesof theneuronalnuclei-
and bromodeoxyuridine-positive cells (3) are as follows: (A1) vehicle-control; (B1) G-CSF alone (30 mg/kg); (C1) perinatal hypoxia plus
vehicle; and (D1) perinatal hypoxiaplusG-CSF (30mg/kg). Thearrows reveal the representativenewly generatedneurons. BarZ 50mm.
G-CSF and neurogenesis in the neonatal brain 385
Figure 4 Quantified analysis of the effects of granulocyte-colony stimulating factor (G-CSF) in the decreased expressions of
neurogenesis in the dentate gyrus, midbrain, and temporal cortex postperinatal hypoxia. The experimental groups are indicated as
follows: vehicle-control (C), G-CSF alone (G), perinatal hypoxia plus vehicle (H), perinatal hypoxia plus G-CSF (HþG). (n Z 10
animals for each experimental group.) Colocalization of neuronal nuclei (NeuN)-positive and bromodeoxyuridine (BrdU)-positive
cells are indicated new neuronal cells. NeuN-positive and BrdU-negative cells are indicated as old neuronal cells. NeuN-negative
and BrdU-positive cells are non-neuronal cells. * p < 0.05 when compared with the vehicle-control group. Data are presented as
mean  standard error of the mean.
386 Y.-N. Yang et alreferencememory tasks in the rats post perinatal hypoxia are
shown in Figure 5. The perinatal hypoxia plus vehicle group
(nZ 11 animals, p < 0.05) had more mean RMEs and WMEs
comparedwith the vehicle-control group in the first few days
of life. The experimental perinatal hypoxia plus G-CSF
(nZ 10 animals, p< 0.05) group had an alleviatedmean RME
and a trend of lower meanWME compared with the perinatal
hypoxia plus vehicle rats in the first few days of life.
Furthermore, the perinatal hypoxia plus vehicle group had a
significant increase in the number of total mean RMEs and
total mean WMEs compared with the vehicle-control group.
The perinatal hypoxia plus G-CSF group showed improved
total mean RMEs and total mean WMEs compared with the
perinatal hypoxia plus vehicle group. These results suggest
that perinatal hypoxia led to a decline in the ability of spatial
memory formation, and that the insult caused by the peri-
natal hypoxia could be rescued after G-CSF therapy.4. Discussion
In this study, we showed that systemic injections of G-CSF
had beneficial effects after perinatal hypoxia on neonatal
rat brains in several brain regions. G-CSF therapy signifi-
cantly abated the decline in neurogenesis in the dentate
gyrus, midbrain, and temporal lobe of the neonatal brains
after experimental perinatal hypoxia. In addition, working
and cued reference memory impairments of the perinatal
hypoxia rats could be also rescued by this therapy.
Using the eight-arm radial maze task, rats in the peri-
natal hypoxia group were shown to have significantly
reduced spatial memory; however, the perinatal hypoxia
with G-CSF therapy group showed significant improvements
in the damage caused by perinatal hypoxia. In addition, the
histological results showed an increase in neurogenesis in
the dentate gyrus in the perinatal hypoxia with G-CSF
therapy group compared with the perinatal hypoxia group.
In previous studies, the hippocampus (including the dentate
gyrus) and temporal cortex have been proven to be related
to spatial working memory,12,29e31 and G-CSF has beenproven to play an important role in the neural cells with
regards to proliferation, differentiation, and integration in
the dentate gyrus for the hippocampus.32 However, the
mechanism by which G-CSF acts in rat pups with experi-
mental perinatal hypoxia is unclear. The current study
provides evidence that G-CSF administration following
injury due to perinatal hypoxia seems to improve working
and cued reference memory by enhancing neurogenesis in
the dentate gyrus of the hippocampus. Interestingly, the
difference in RMEs and WMEs between the three groups
seemed to decrease after repeat daily training. This spon-
taneous improvement of spatial memory in the perinatal
hypoxia group may be due to repeat training, because an
enriched environment is thought to accelerate neuronal
development in the dentate gyrus of rats.33 Our radial maze
task findings may suggest that early rehabilitation is useful
in alleviating cognitive impairment caused by perinatal
hypoxia.
The benefits and possible mechanisms after G-CSF
therapy have been reported to be through several effects.17
In the central nervous system, G-CSF therapy acts in neu-
rons through G-CSF receptors.15,18 G-CSF may affect neu-
roprotection through neurogenesis, antiapoptotic, anti-
inflammatory, neurotrophic, and angiogenesis effects in
the mammalian adult brain.15e21,34,35 Previous studies have
shown that G-CSF has neurogenesis effect in nonischemic or
healthy brain of adult rodents.18 However, in this study
there was no statistical difference in neurogenesis between
the G-CSF alone and vehicle-control group. Thus, it is
noteworthy that this discrepancy may be due to different
animal species and ages, as well as different hypoxia
protocol.
cAMP response element-binding protein phosphorylated
at serine 133 (pCREBSer-133) has been shown to lead to
synaptogenesis, neuronal survival with neurogenesis, and
synaptic plasticity in the brain.36e38 In addition, CREB is a
DNA-binding transcription factor and plays an important
role in the regulation of some immediate-early genes.39
Previously, we reported that G-CSF therapy alleviates the
decreased in pCREBSer-133 and postsynaptic density protein
Figure 5 Impairment of the long-term performance of
working and cued reference memory was found using an eight-
arm radial maze task after experimental perinatal hypoxia. (A)
One trial/day over 15 trials, average amount of cued reference
memory errors, and the inset box reveals the average of total
mean reference memory errors. (B) One trial/day over 15 tri-
als, average amount of working memory errors, and the inset
box reveals the average total mean working memory errors.
Vehicle-control ( n Z 10 animals), perinatal hypoxia plus
vehicle (O; n Z 11 animals), perinatal hypoxia plus
granulocyte-colony stimulating factor (;; n Z 10 animals),
are labeled as C, H, and H þ G, respectively. Statistical analysis
of the long-term performance of the working and cued refer-
ence memory revealed that the rats with perinatal hypoxia
plus vehicle significantly differed from those in the vehicle-
control and perinatal hypoxia plus granulocyte-colony stimu-
lating factor groups. *p < 0.05, when compared with the
vehicle-control group.
G-CSF and neurogenesis in the neonatal brain 38795 with N-methyl-D-aspartate receptor subunits within the
CA1 region of the hippocampus after perinatal hypoxia, and
provides beneficial effects in long-term cognitive deficits.22
However, whether the neuroprotective effects of G-CSF are
also displayed in multiple brain regions after experimental
perinatal hypoxia was unknown. Hence, we investigated
this in the current study and showed that the efficacy of G-
CSF therapy in neurogenesis after perinatal hypoxia was not
only in the CA1 region of the hippocampus but also in the
dentate gyrus, midbrain, and temporal region with long-
term cognitive effects. The neurogenesis effect of G-CSF
may thus work in several brain regions and even in thewhole brain. Extensive brain damage is caused by perinatal
hypoxia, and G-CSF may provide substantial brain neuro-
genesis. In addition, G-CSF therapy enhanced neurogenesis
but did not rescue all old neural and non-neural cells
(Figure 4). The specificity of G-CSF may provide a new
therapy strategy in the future. However, it is still unclear
what type of neuronal cells, surviving neurons, or neuronal
progenitor cells that G-CSF acts on to drive to neurogenesis
in this study. Indeed, the G-CSF receptor can be expressed
on various cell types, including hematopoietic stem cells
(HSCs).40 G-CSF can enhance translocation of HSCs to the
ischemic brain and improve neuronal plasticity and vascu-
larization.20 Thus, in our experiments, there is a possibility
that neurogenesis effect of G-CSF in perinatal hypoxia pups
may also due to mobilizing HSCs into the brain and facili-
tating neurogenesis through neurotropic factors released or
stimulated by HSCs.
In conclusion, this study showed that G-CSF therapy was
able to recover the perinatal hypoxia-induced decline in
neurogenesis in rats, and, at least in part, improve the long-
term functional outcomes (in the impaired performance in
spatial working and cued reference memory). In addition,
environment enrichment may provide a better outcome in
perinatal hypoxia subjects, and early rehabilitation may be
useful. This study suggests a useful and new potential
neuroprotective strategy that may be well tolerated with
fewer side effects in the neonatal brain after hypoxic epi-
sodes. Although we are far from being able to apply this
therapy in human neonates, our results provide an insight
into neurological function defects in patients after
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